I
n polycystic kidney disease (PKD), the aberrant growth of renal tubule epithelial cells leads to the formation of fluidfilled cysts, massive enlargement of kidneys, and a decline in renal function (1) . Mutations in the genes associated with human PKD (PKD1, PKD2, and PKHD1) transform tubule epithelial cells into benign hyperplastic cysts. Renal failure develops as cysts progressively enlarge and replace the normal parenchyma.
Autosomal dominant PKD (ADPKD) is caused by genetic mutations in either the PKD1 or the PKD2 gene (2) (3) (4) . It now is thought that renal epithelial cell hyperplasia in ADPKD is a consequence of dysfunctional Ca 2ϩ metabolism owing to mutations that affect the polycystin proteins. Polycystin-1 (PC-1) and PC-2, the protein products of the PKD1 and PKD2 genes, respectively, have been shown to assemble at the plasma membrane to regulate a Ca 2ϩ entry mechanism (5) . PC-1 may act as a receptor that gates Ca 2ϩ -permeant PC-2 channels. PC-2 has also been reported to be a Ca 2ϩ release channel in the endoplasmic reticulum (6) . Defects in either PC-1 or PC-2 are thought to disrupt intracellular Ca 2ϩ homeostasis or Ca 2ϩ signaling leading to cellular dedifferentiation and hyperproliferation.
Autosomal recessive PKD (ARPKD) is caused by mutations in PKHD1, a gene that encodes a novel protein, fibrocystin (polyductin) (7, 8) . The function of fibrocystin is unknown; however, in common with other proteins associated with PKD pathogenesis, fibrocystin localizes to the primary cilium on renal epithelial cells (9) , a structure that is thought to transduce a Ca 2ϩ signal in response to mechanical or chemical stimulation (10, 11) . The specific roles of PC-1, PC-2, and fibrocystin in [Ca 2ϩ ] i regulation and the processes by which mutations in their genes cause epithelial cell hyperplasia and renal cyst formation remain unclear.
cAMP has a central role in cystogenesis by stimulating both transepithelial fluid secretion (12, 13) and the proliferation of cyst epithelial cells (14 -16) . In vitro studies have demonstrated that cAMP agonists, including arginine vasopressin (AVP), promote the proliferation of epithelial cells derived from human ADPKD (14 -16) and ARPKD (17) kidneys. By contrast, cAMP agonists inhibit the proliferation of normal human kidneys (NHK) cells. Recently, AVP and cAMP were shown to have primary roles in the progressive enlargement of cysts in animal models of ARPKD (PCK rat), ADPKD (Pkd2 ws25/Ϫ mouse), nephronophthisis (pcy mouse), and a unique recessive cystic disorder (cpk mouse) (18 -21) . Vasopressin V2 receptor blockade decreased renal cAMP levels and strikingly reduced the size of the cystic kidneys. Thus, it seems that renal cyst growth in hereditary cystic disorders depends on a common cellular pathway incorporating cAMP. The molecular mechanism for the phenotypic differences in the cAMP mitogenic response between NHK and ADPKD cells is linked to cAMP-dependent B-Raf signaling to MEK, a kinase that stimulates extracellular signal-regulated kinases (ERK) (15) . In ADPKD cells, cAMP activates B-Raf to stimulate the MEK/ERK pathway and cell proliferation. In NHK and M-1 cells, cAMP decreases the rate of cell proliferation through inhibition of the Ras/Raf-1/MEK/ERK pathway by decreasing Raf-1 activity. Normally, B-Raf activity is repressed by Akt (protein kinase B) involving a phosphatidylinositol 3-kinase (PI 3-K)-dependent pathway (22) . Restriction of intracellular Ca 2ϩ with Ca 2ϩ channel blockers is able to relieve B-Raf inhibition by Akt, thereby allowing cAMP activation of the B-Raf/MEK/ERK pathway and cell proliferation. Inhibition of Akt or PI 3-K also allowed cAMP-dependent activation of B-Raf and ERK and increased proliferation. Those studies demonstrated that restriction of intracellular Ca 2ϩ in normal cells can induce a switch such that cAMP activates B-Raf/MEK/ERK and cell proliferation, mimicking the PKD phenotype (22) .
Because Ca 2ϩ restriction can be shown to switch normal cells to the PKD phenotype, we reasoned that Ca 2ϩ elevation may be able to rescue PKD cells. Thus, in this study, we sought to determine whether an elevation in Ca 2ϩ in ADPKD and ARPKD cells can repress cAMP activation of the B-Raf /MEK/ERK pathway and cell proliferation and restore a normal cellular phenotype.
Materials and Methods

Primary Cultures of Human Kidney Epithelial Cells
Normal regions of human kidneys, confirmed by histologic examination, were collected from nephrectomy specimens that were removed for the treatment of renal carcinomas. Normal kidneys that were withheld from transplantation as a result of anomalous vasculature were also obtained from the Midwest Transplant Network (Kansas City, KS). ADPKD kidneys are obtained from hospitals that participate in the Polycystic Kidney Research Retrieval Program with the assistance of the PKD Foundation (Kansas City, MO). An ARPKD nephrectomy specimen was obtained from a 2-wk-old enfant at a local hospital. A protocol for the use of discarded human tissues complies with federal regulations and was approved by the Institutional Review Board at the University of Kansas Medical Center.
Tissues were minced and digested overnight in DMEM/F12 (1:1) mixture that contained 220 IU/ml type IV collagenase and 100 IU/ml penicillin G and 0.1 mg/ml streptomycin (P/S) (13) . Collagenase digestion was stopped by the addition of FBS. Cells were rinsed in medium and propagated in DMEM/F12 supplemented with 5% FBS, 5 g/ml insulin, 5 g/ml transferrin, and 5 ng/ml sodium selenite (ITS) and P/S. At 70 to 80% confluence, cells were lifted from the plastic and either frozen in medium that contained 10% DMSO for storage in liquid N 2 or seeded directly onto supports for experiments.
Measurement of Intracellular Ca 2ϩ
For preparing NHK, ADPKD, and ARPKD cells for Ca 2ϩ imaging, cells were cultured on glass coverslips that were coated with fibrillar type I collagen in DMEM/F12 that contained 5% FBS. After 2 d, serum was reduced to 1% for an additional day. Then, the cells were incubated in 0.002% FBS for 24 h before the experiment to reduce serum factors that alter basal Ca 2ϩ levels and to limit variations in resting [Ca 2ϩ ] i . The morphology of the NHK, ADPKD, and ARPKD cell monolayers (approximately 80% confluent) was similar. (22) . The chamber was perfused continuously at 3 ml/min with Ringer's solution equilibrated with 5% CO 2 /95% air at 37°C to ensure exchange of the 1-ml bath volume.
Fura-2 measurements were made with dual excitation wavelengths of 340 and 380 nm, and the emitted light at 510 nm was measured with a digital photomultiplier detection system (Photon Technology International, South Brunswick, NJ). Felix 32 analysis software (PTI) controlled the monochromator and data acquisition to generate the 340/380 fluorescence ratio (23) . For each monolayer, 340/380 excitation ratios (collected over a 2.5-min interval) were measured at five different locations. At the end of each experiment, cells were permeabilized with 1 M ionomycin in Ringer's solution that contained 2 mM Ca 2ϩ to determine the maximum 340/380 ratio (R max ), and then 10 mM EGTA was added to determine R min . The 340/380 ratios were converted to [Ca 2ϩ ] using 
Cell Proliferation Measurements
NHK, ADPKD, and ARPKD (4 ϫ 10 3 /well) cells were seeded in a 96-well culture plate and incubated for 24 h in DMEM/F12 with 1% FBS, ITS, and P/S. The FBS concentration was reduced to 0.002% and ITS was removed, and the cells were incubated for 24 h before the addition of 100 M 8-Br-cAMP (cAMP), 1 M Bay K8644, 0.01 M A23187, 0.1 M nifedipine, 1 M verapamil, or 5 M Akt inhibitor (6 wells/condition). After 72 h, cell proliferation was determined by the Promega Cell Titer 96 MTT assay method (14) .
Immunoblot Assay
Cells (0.5 to 1 ϫ 10 6 ) were seeded onto plastic petri dishes (100 mm) that contained DMEM/F12 medium with 1% FBS. The serum was reduced to 0.002% at approximately 75% confluence, and the cells were allowed to grow for an additional 24 h. The cells then were treated with 1 M Bay K8644, 0.01 M A23187, and/or 5 M Akt inhibitor for 24 h, and cAMP was added for the final 15 min before cell lysates were prepared (15) . Immunoblots were probed with antibodies for ERK-1 (C-16), ERK-2 (C-14), Akt (C-20), and phospho-ERK (P-ERK; E-4) from Santa Cruz Biotechnology (Santa Cruz, CA). Phospho-Akt (Ser 473) and phospho-MEK were purchased from Biosource (Camarillo, CA). Secondary anti-rabbit, -mouse, -rat, or -goat IgG-conjugated horseradish peroxidase secondary antibodies were from Santa Cruz.
B-Raf Immune Complex Kinase Assay
Clarified cell lysates were immunoprecipitated for 2 h with gentle rotation at 4°C with anti-B-Raf antibody (C-19; Santa Cruz) bound to agarose beads (15, 22) . Precipitates were rinsed and incubated for 30 min at 30°C in a nonradioactive B-Raf kinase assay that contained ATP and MEK-1 fusion protein (Santa Cruz) as substrates for the reaction. Phosphorylated MEK, a measure of B-Raf kinase activity, was deter-mined by immunoblot using an antibody to phospho-MEK. Phospho-MEK was detected and quantified with a Fluor-S MAX imager.
Growth Measurement of Cultured ADPKD Cysts
Primary cultures of ADPKD cells (4 ϫ 10 3 cells/well) were dispersed within an ice-cold type I collagen matrix (Vitrogen; Collagen Corp., Palo Alto, CA) in wells of a 96-well culture plate (13) . Warming the plate to 37°C caused polymerization of the collagen, trapping the cells within the gel. A defined medium (DMEM/F12 with ITS, 5 ϫ 10 Ϫ8 M hydrocortisone, and 5 ϫ 10 Ϫ5 M triiodothyronine) supplemented with 5 M forskolin and 5 ng/ml EGF was added for 3 d to initiate cyst growth. The diameters of cysts after 3 d were Ͻ100 m. EGF was removed, and then 5 M forskolin and 10 M Bay K8644 were added for an additional 9 d. Outer diameters of cross-sectional images of spherical cysts with distinct lumens were measured using an inverted microscope with a digital camera and video analysis software. The total surface area (SA) of the cysts within each well was calculated from the individual cyst diameters (cysts Ն100 m). These experiments were repeated with a total of three cell preparations from different ADPKD kidneys.
Results
Measurement of [Ca 2ϩ ] i in NHK, ADPKD, and ARPKD Cells
If cyst development is a consequence of dysfunctional intracellular Ca 2ϩ homeostasis, then cells that are derived from these cysts might be expected to have altered basal Ca 2ϩ levels. Primary epithelial cell cultures were prepared from the cortex (1 to 3 mm from the surface) of NHK or multiple surface cysts of ADPKD kidneys as described previously (13) (14) (15) 25) . Cells appeared pleomorphic and stained with Arachis hypoaea (PNA) and Dolichos biflorus agglutinin (DBA) lectins, suggesting distal tubule or collecting duct origin (15) . Subconfluent monolayers lacked detectable surface cilia, in contrast to the presence of cilia on 4-d postconfluent monolayers as assayed with an antibody to acetylated tubulin (data not shown). For measurement of [Ca 2ϩ ] i , cells that were derived from ADPKD and NHK kidneys (n ϭ 3 each) were loaded with Fura-2. We found that steady-state [Ca 2ϩ ] i in cultured ADPKD cells (56.5 Ϯ 2.1 nM) was 20 nM lower than in cultured NHK cortex cells (76.5 Ϯ 1.8 nM; Figure 1 ).
Heterozygous loss of PC-2 has been shown to be sufficient to decrease resting Ca 2ϩ levels in vascular smooth muscle cells (26) . For comparing [Ca 2ϩ ] i between cells that were derived from AD-PKD cysts (which are likely to have a homozygous loss of one of the polycystins) and normal-looking tubules in ADPKD kidneys (which are heterozygous), epithelial cells were cultured from surface cysts ( Figure 2A ) and adjacent noncystic tissue ( Figure 2B ) from the same ADPKD kidneys. These patients (n ϭ 2) had relatively normal renal function; one kidney was removed from each patient for the treatment of severe pain. [Ca 2ϩ ] i of cells that were derived from the ADPKD cysts (40.6 and 49.7 nM) were 21.9 and 23.1 nM lower than noncystic cells (62.5 and 72.8 nM, respectively; Table 1 ). Thus, it seems that cyst epithelial cells have significantly lower [Ca 2ϩ ] i as compared with either homozygous normal or ADPKD heterozygous cells.
Basal intracellular Ca 2ϩ levels were also measured in subconfluent ARPKD cells that were derived from a nephrectomy specimen. For these experiments, ARPKD and NHK cells were grown under identical growth conditions, and intracellular Ca 2ϩ concentrations were determined in paired monolayers. We found that ARPKD cells had a significantly lower basal Ca 2ϩ concentration compared with NHK cells (66.8 Ϯ 1.4 versus 74.4 Ϯ 1.1 nM; P Ͻ 0.0005; n ϭ 11 monolayers). Further studies are required to determine whether basal Ca 2ϩ levels and/or flow-dependent Ca 2ϩ signaling differ among NHK, ADPKD, and ARPKD cells that express primary cilia.
Proliferation Response to cAMP of Cystic and Noncystic Cells from ADPKD Kidneys
Our observation that noncystic cells from ADPKD kidneys have steady-state Ca 2ϩ levels comparable to NHK cells suggests that these cells might have a normal cellular response to cAMP. Indeed, in noncystic ADPKD cells, cAMP inhibited ERK activity ( Figure 2D ) and decreased the rate of cell proliferation ( Figure 2F ), a phenotype similar to NHK and M-1 cells. By contrast, in cells that were derived from the cysts, cAMP stimulated ERK activity ( Figure 2C ) and increased the rate of cell proliferation ( Figure 2E ). Together, these data indicate that cells from normal-appearing tubules in ADPKD kidneys have normal intracellular Ca 2ϩ levels and an anti-mitogenic response to cAMP. Thus, germline mutations in the PKD genes alone seem to be insufficient to disrupt Ca 2ϩ levels to the degree that can initiate the phenotypic switch to a cAMP-mitogenic response.
Treatment of noncystic ADPKD cells with Ca 2ϩ channel blockers verapamil and nifedipine reversed the cAMP re- ] i and the mitogenic response to cAMP, we measured proliferation rates for both AD-PKD and ARPKD cystic cells that were incubated in cAMP alone or in combination with either Bay K8644 or A23187. cAMP increased the proliferation of ADPKD ( Figure 4A ) and ARPKD cells ( Figure 4B ), consistent with previous reports (14, 17) . Elevation in intracellular Ca 2ϩ with Bay K8644 (1 M) or Ca 2ϩ ionophore A23187 (0.01 M) had no effect on the basal rates of proliferation but completely reversed the proliferative response to cAMP in both ADPKD and ARPKD cell cultures. Thus, repletion of intra- ] i prevents cAMP-dependent proliferation of cultured ADPKD and autosomal recessive PKD (ARPKD) cells. Cells that were derived from the cysts of ADPKD kidneys (A) and an ARPKD kidney (B) were cultured in medium that contained 1% FBS ϩ ITS for 24 h, and then the serum was reduced to 0.002% for an additional 24 h before treatment. Cells were incubated with 1 M Bay K8644 (Bay K) or 0.01 M Ca 2ϩ ionophore A23187 and/or 100 M 8-BrcAMP (cAMP) for 72 h. 
Elevation of [Ca 2ϩ ] i Inhibits cAMP-Dependent Cyst Formation of ADPKD Cells In Vitro
For investigating the effect of intracellular Ca 2ϩ on cAMPdependent proliferation under conditions that more closely resemble cyst growth in situ, ADPKD cells were cultured within polymerized collagen gels and stimulated to form cysts. Cysts develop within a collagen matrix from the clonal growth of individual ADPKD cells after treatment with EGF and forskolin, a cAMP agonist. After cyst formation is initiated, EGF is removed and forskolin and Bay K8644 are added individually or together to the culture medium. Forskolin increased both the number and the size of cysts ( Figure 5A ) and increased the total SA of cysts (diameter Ն 100 m) per well ( Figure 5B ). Bay K8644 in the presence of forskolin reduced the total SA of the cysts to below the control level, suggesting that restoration of intracellular Ca 2ϩ can block cAMP-dependent growth of AD-PKD cysts in culture. Upon removal of Bay K8644, cysts resumed growth and enlarged at a steady rate, establishing that the effect of Bay K8644 is reversible (data not shown). Thus, increasing [Ca 2ϩ ] i is able to block cAMP-dependent cell proliferation and in vitro cyst formation of ADPKD cells in culture.
Elevation of [Ca 2ϩ ] i Represses cAMP-Dependent B-Raf Signaling to MEK-ERK Pathway in ADPKD Cells
B-Raf is a central intermediate that relays signals from receptor-mediated cAMP activation to the MEK/ERK pathway in ADPKD cells (15) and M-1 cells that are subjected to Ca 2ϩ restriction (22) . cAMP increased the levels of P-ERK by 80% ( Figure 6A ) in ADPKD cells (n ϭ 6 kidneys) and the relative B-Raf kinase activity by 100% ( Figure 6B ). To determine whether an increase in intracellular Ca 2ϩ in ADPKD cells can repress cAMP-dependent B-Raf activation, we measured P-ERK levels and B-Raf kinase activity after treatment with Bay K8644 and A23187. Elevation of intracellular Ca 2ϩ with Bay K8644 or A23187 prevented ERK activation by cAMP ( Figure  6A ). Bay K8644 diminished basal ( Figure 6B ) and cAMP-induced activities of B-Raf, implicating a role for both ERK and B-Raf in Ca 2ϩ regulation of the proliferative response to cAMP. 
Elevation of [Ca 2ϩ ] i Activates Akt to Repress cAMPDependent B-Raf Signaling to MEK/ERK Pathway
Akt has been shown to negatively regulate B-Raf activity by phosphorylation of an inhibitory site on B-Raf (27) . Previously in M-1 cells, we found that the PI 3-K/Akt pathway regulates cAMP-dependent activation of B-Raf/MEK/ERK and cell proliferation. Reduction of [Ca 2ϩ ] i decreased Akt activity and allowed cAMP-dependent B-Raf activation and cell proliferation. Direct inhibition of either PI 3-K or Akt caused cAMP-dependent ERK activation and cell proliferation, thus inducing a phenotypic switch that imitates Ca 2ϩ restriction (22) . To determine whether the difference in the mitogenic response to cAMP between NHK and ADPKD cells is associated Akt activity, we measured the levels of P-Akt (active) and total Akt by immunoblot analysis. The average ratio of P-Akt/total Akt was 63% higher in NHK cells compared with ADPKD cells (n ϭ 4 kidneys each; Figure 7A ). To determine whether changes in intracellular Ca 2ϩ alter Akt activity, we treated ADPKD cells with Bay K8644, A23187, verapamil, or nifedipine for 15 min. Elevation of Ca 2ϩ with Bay K8644 and A23187 increased P-Akt levels by 66.0 and 64.8%, respectively ( Figure 7B ), whereas the Ca 2ϩ channel blockers decreased P-Akt by 21 and 22%, respectively.
We next examined the effect of selective inhibition of Akt on the proliferative response in ADPKD cells. Cells were treated with 8-Br-cAMP, Akt inhibitor 1L-6-hydroxymethyl-chiro-inositol 2-(R)-2-O-methyl-3-O-octadecylcarbonate, or a combination of the two agents. Inhibition of Akt increased the rate of cAMP-dependent cell proliferation (Figure 8 ), indicating that cAMP-dependent B-Raf activation of MEK/ERK and cell proliferation is still under some degree of regulation by Akt in cyst epithelial cells. These data suggest that the effect of cAMP to activate the B-Raf/MEK/ ERK pathway is controlled by the activity of Akt, which in turn is governed by intracellular Ca 2ϩ . These data are consistent with the hypothesis that reduced steady-state [Ca 2ϩ ] i in cyst-derived cells lowers basal Akt activity and allows cAMP-dependent B-Raf activation of the MEK/ERK pathway and cell proliferation. These data further show that restoration of intracellular Ca 2ϩ in cyst-derived cells increases the Akt activity and consequently represses B-Raf, allowing cAMP inhibition of Raf-1/MEK/ERK and cell proliferation.
Discussion
Abnormal epithelial cell proliferation underlies cyst formation and renal enlargement in both ADPKD and ARPKD. EGF, an agonist for the receptor tyrosine kinase EGFR, activates the Ras/Raf-1/MEK/ ERK pathway and proliferation of both PKD cells and NHK cells (Figure 9 ). The discovery that cAMP stimulates the proliferation of ADPKD cells but inhibits the proliferation of NHK cells demonstrates a unique phenotypic difference between PKD and NHK cells. In NHK cells, cAMP has been shown to inhibit the Ras/Raf-1/MEK/ ERK pathway at the level of Raf-1 and decrease cell proliferation ( Figure 9A ). By contrast, in PKD cells, cAMP has been shown to stimulate B-Raf and activate the MEK/ERK pathway to increase cell proliferation ( Figure 9B ).
The molecular basis by which mutations in the polycystins induce a cAMP-mitogenic phenotype in ADPKD cells remains to be established, but dysfunctional Ca 2ϩ regulation is likely to be involved. Several lines of evidence indicate that PC-1 and PC-2 have roles in intracellular Ca 2ϩ regulation (5, 6, 10, 23, (28) (29) (30) . As such, mutations in the PKD genes may disrupt intracellular Ca 2ϩ metabolism, leading to aberrant proliferation of the renal epithelium and cyst formation. In ADPKD, cysts form in only a minority of the nephrons, although all cells carry the germline mutation. A "two-hit" mechanism has been proposed to explain the focal nature of cyst formation, suggesting that cysts originate in cells that have homozygous inactivation of one of the PKD genes, resulting from combined germline and somatic mutations (31) (32) (33) (34) (35) . In contrast, there is evidence that PKD haploinsufficiency may be sufficient to induce vascular defects (26) and that simply reducing PC-1 expression below a critical level may induce cystogenesis (36) .
In our study, cells that were derived from ADPKD cysts were found to have basal [Ca 2ϩ ] i approximately 20 nM lower than either NHK cells or cells that were derived from noncystic regions of ADPKD kidneys. This observation that noncystic ADPKD cells and NHK cells have similar [Ca 2ϩ ] i suggests that a "second-hit" mechanism may be necessary to decrease intracellular Ca 2ϩ levels in renal epithelial cells. Human ARPKD cells also were found to have reduced basal Ca 2ϩ levels compared with NHK cells, suggesting that mutations in either the polycystins or fibrocystin lead to a Ca 2ϩ defect in renal epithelial cells. The data presented in this study provide evidence that intracellular Ca 2ϩ is a central regulator of the mitogenic response to cAMP in human renal epithelial cells. In the noncystic ADPKD cells, cAMP decreased ERK activity and inhibited cell proliferation. In contrast, in cyst-derived ADPKD cells, cAMP stimulated ERK and cell proliferation (Figure 2) . Thus, cyst-derived cells, which presumably have both germline and somatic mutations in the PKD gene, had a lower [Ca 2ϩ ] i and a cAMP-dependent proliferative phenotype, whereas noncystic cells from ADPKD kidneys had a normal [Ca 2ϩ ] i and a normal anti-proliferative phenotype. Reduction of [Ca 2ϩ ] i in noncystic cells with Ca 2ϩ channel blockers reversed the mitogenic response to cAMP such that cAMP stimulated ERK and cell proliferation, mimicking the cystic cells. These types of reversal experiments strongly implicate a relationship between intracellular Ca 2ϩ and cAMP-dependent cell proliferation and cyst formation.
In this study, we did not determine the specific mutations in either ADPKD or ARPKD cells. It is interesting to note that the steady-state Ca 2ϩ levels were decreased in both ADPKD and ARPKD cells. Moreover, the addition of Ca 2ϩ to ADPKD and ARPKD cells reversed the capacity of cAMP to stimulate cell proliferation. We think that the reduced steady-state intracellular Ca 2ϩ levels, common to both ADPKD and ARPKD cells, and the reversal of the cAMP-dependent proliferation by increasing cell Ca 2ϩ support the view that reduced intracellular Ca 2ϩ alters the cAMP-proliferative response irrespective of the underlying mutations in either ADPKD or ARPKD.
Previously, the mitogenic response to cAMP had been induced experimentally by reducing [Ca 2ϩ ] i in M-1 cells with Ca 2ϩ channel blockers or EGTA (22) . Restriction of intracellular Ca 2ϩ switched these cells from cAMP-growth inhibited to cAMP-growth stimulated, mimicking the PKD phenotype. On the basis of those stud- ies, we proposed that Ca 2ϩ acts to maintain Akt activity, which suppresses B-Raf signaling to the mitogen-activated protein kinase pathway in normal renal epithelial cells. Akt phosphorylation of B-Raf can block the activity of B-Raf, preventing cAMP activation of ERK and cell proliferation (27) . Ca 2ϩ restriction in M-1 cells decreased Akt activity, allowing cAMP-dependent activation of B-Raf and cell proliferation (22) .
If the loss of polycystin in ADPKD cells were to diminish [Ca 2ϩ ] i , then one might expect that the basal Akt activity would be lower. In our study, relative levels of P-Akt/total Akt were found to be significantly lower in ADPKD cells compared with NHK cells ( Figure 7A ). Bay K8644 and A23187 caused a sustained increase in [Ca 2ϩ ] i ( Figure 3A) and completely reversed the cAMP proliferative response in both ADPKD and ARPKD cells ( Figure  4 ). This phenotypic switch in the cAMP-mitogenic response was associated with an increase in Akt activity ( Figure 7 ) and decreased B-Raf and ERK activities ( Figure 6 ).
In conclusion, these data support the hypothesis that intracellular Ca 2ϩ has an important role in determining the proliferative response to cAMP agonists in renal epithelial cells (Figure 9 ). The reduction in [Ca 2ϩ ] i in cyst epithelial cells, secondary to mutations in the PKD genes, relieves Akt inhibition of B-Raf, allowing cAMP-dependent cell proliferation and cyst growth. We found that an increase in Ca 2ϩ in PKD cells can increase Akt activity to repress cAMP stimulation of B-Raf, ERK, and cell proliferation, thus restoring a normal anti-mitogenic response to cAMP. Therapeutic approaches to reduce renal cAMP accumulation by blocking the vasopressin V2 receptors are being considered for the treatment of PKD (14, 17) . We propose that mechanisms that selectively increase [Ca 2ϩ ] i within renal cystic epithelial cells might provide an alternative or complementary treatment to retard cAMP-dependent cyst progression. 
